Evaluation of Transcranial Doppler Vasoconstrictor Vasoreactivity During General Anesthesia in Hypertensive Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-02

Study Completion Date

2019-04-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During a general anesthesia, people over 65 years old and hypertensive, have a modification of the vasoreactivity and their cerebral blood flow under vasoconstrictor such as norepinephrine or phenylephrine. We study the variation of the average velocity of the average cerebral artery under vasoconstrictor and during a modification of End Tidal CO2 (EtCO2) by transcranial Doppler.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Blood Pressure in the Emergency Department

NCT03954119

Blood Pressure Hypertension Emergencies

COMPLETED

Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake

NCT03558022

Hypertension

COMPLETED NA

The Effects of Blood Pressure Reduction on Cerebral Perfusion and Cognition in the Elderly Population

NCT00966199

Hypertension

UNKNOWN PHASE4

Changes in Measured Plasma Volume, Glycocalyx and Atrial Natriuretic Peptide During Anaesthesia

NCT02832596

Blood Pressure Anesthesia

COMPLETED NA

Sympathetic Activity and Renal Denervation

NCT01355055

Hypertension

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

General anesthesia induces a sympathetic block frequently leading to hypotension, especially in elderly and hypertensive patients. Currently, Phenylephrine (PE) and Norepinephrine (NE) are commonly used in clinical practice to address this arterial pressure drop. Their cardiovascular effects are not exactly the same, even though they both increase mean blood pressure.

Maintenance of mean arterial pressure is not the only hemodynamic goal during general anesthesia in the elderly. Cognitive disorders have been demonstrated during post-anesthetic awakening.

Cerebral hemodynamics is assessed by analyzing the speed of blood flow in the middle cerebral artery using transcranial Doppler (DTC). It measures the systolic and diastolic speed as well as the pulsatility index, which are predictive factors for lowering cerebral blood flow.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertensive Disease Elderly Vasopressors General Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients under vasoconstrictor

Patients older than 65 years old and hypertensive, requiring vasoconstrictor (phenylephrine or Neosynephrine) during general anesthesia.

Transcranial Doppler (DTC)

Intervention Type OTHER

Evaluation of Vasoconstrictor Vasoreactivity with Transcranial Doppler

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transcranial Doppler (DTC)

Evaluation of Vasoconstrictor Vasoreactivity with Transcranial Doppler

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* older over 65 years
* high blood pressure disease
* need general anesthesia
* need vasopressors : norepinephrine or phenylephrine
* temporal window of transcranial doppler is viable

Exclusion Criteria

* Acute, valvular, rhythmic or ischemic cardiovascular pathology
* severe arthritis (stage 3)
* Intra-cranial pathology
* Significant carotid stenosis (\> 40%) or carotid endarterectomy
* Cervical surgery
* Taking a premedication that can modify cerebral vasoreactivity
* Insulin-dependent diabetes for more than 10 years
* Person under judicial protection
* Opposition to data processing

Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No